Skip to Content

Notice

Manufacturer of Controlled Substances; Notice of Application

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 25, 2006, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II:

DrugSchedule
N-Ethylamphetamine (1475)I
2,5-Dimethoxyamphetamine (7396)I
4-Methoxyamphetamine (7411)I
Difenoxin (9168)I
Dihydromorphine (9145)I
Amphetamine (1100)II
Methamphetamine (1105)II
Methylphenidate (1724)II
Pentobarbital (2270)II
Secobarbital (2315)II
Codeine (9050)II
Dihydrocodeine (9120)II
Oxycodone (9143)II
Hydromorphone (9150)II
Diphenoxylate (9170)II
Hydrocodone (9193)II
Meperidine (9230)II
Dextropropoxyphene, bulk (non-dosage forms) (9273)II
Morphine (9300)II
Thebaine (9333)II
Opium Extracts (9610)II
Opium Fluid Extract (9620)II
Opium Tincture (9630)II
Opium, Granulated (9640)II
Oxymorphone (9652)II
Noroxymorphone (9668)II
Opium, Powdered (9639)II
Alfentanil (9737)II
Sufentanil (9740)II
Fentanyl (9801)II

The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR § 1301.33(a). Start Printed Page 69590

Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative/ODL; or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than January 30, 2007.

Start Signature

Dated: November 21, 2006.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. E6-20339 Filed 11-30-06; 8:45 am]

BILLING CODE 4410-09-P